AstraZeneca Seeks Growth With New Drugs As COVID Sales Dwindle
Summary Sees profit increase in 2023 Investors focus on margins in 2023 as operating expenses grow ...
Read moreSummary Sees profit increase in 2023 Investors focus on margins in 2023 as operating expenses grow ...
Read moreSummary AZN shares slide 1% on Monday Farxiga-baxdrostat combination could prolong franchise - AZN exec Fall ...
Read moreSummary Evusheld gain to more than offset decline in COVID vaccine Profit guidance unchanged due to ...
Read more© Copyright 2024 EconIntersect